Email this page |
|
Enlarge Shrink Hide Show Algorithm |
Augmentation
- Click here for psychotherapy resources (best evidence for CBT in augmentation)
- Other non-medication augmentation options (second-line as per CANMAT 2023 guidelines) for moderate severity MDE include:
If using a medication for augmentation, consider this two step process:
Step 1*
Choose:
- for those with insomnia and who can tolerate weight gain consider mirtazapine 30 mg po qhs x 2 weeks. If less than 20% response and tolerating it, consider increasing to 45 mg po qhs, OR
- for those without risk factors for seizures and who are lacking energy consider bupropion XL 150 mg po daily x 2 weeks. If less than 20% response, consider increase to 300 mg po daily**
- If on either bupropion or mirtazapine as an initial agent, consider augmenting with an SSRI or SNRI
If Step 1 interventions are ineffective or not tolerated, then proceed to Step 2…
Step 2
Choose:
- Aripiprazole 2 mg po daily x 2 weeks. If less than 20% response increase to 5 mg po daily, OR
- for those sleeping poorly and who can tolerate weight gain quetiapine XR 50 mg po at supper x 1 week. If tolerated then increase it to 150 mg po q supper. If less than 20% response after 2 weeks and if tolerated then consider increase to 300 mg po q supperB
- Brexpiprazole is also approved for augmentation and can be started at 0.5 mg po daily (or at night) and increased in increased in increments of 0.5 mg every 2 weeks, based on response an tolerance, to a maximum dose of 2.0 mg as required
- Note:
- While on antipsychotics need to check lipids, fasting glucose or HbA1c and weight at baseline, at 3 months, and periodically thereafter
- If no response to antipsychotic augmentation we suggest tapering and removing the antipsychotic over several weeks to avoid unnecessary side effects
- If there is a good response to antipsychotic augmentation try to taper and remove the antipsychotic gradually after 6-9 months to avoid unnecessary side effects
* Note: CANMAT recommends antipsychotics as first line augmentation options but due to side effect profile we have recommended them as second line options.
** If adding bupropion to vortioxetine may need to decrease dose of vortioxetine